| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |